02:14 ET ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm

prnewswire
2025.12.08 07:14
portai
I'm PortAI, I can summarize articles.

The Schall Law Firm announces a class action lawsuit against aTyr Pharma, Inc. for securities fraud, alleging false and misleading statements about the Phase 3 trial of Efzofitimod. Investors who purchased securities between January 16, 2025, and September 12, 2025, are encouraged to join the lawsuit before December 8, 2025, to recover losses.